CytomX Therapeutics Historical PE Ratio image   This CTMX PE ratio history page last updated 3/25/2024
CytomX Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/11/2024
2.510.010.0462.7
Q3 2023
11/7/2023
1.280.040.168.0
Q2 2023
8/8/2023
1.69-0.02-0.08NA
Q1 2023
5/9/2023
1.72-0.05-0.20NA
Q4 2022
3/27/2023
1.79-0.42-1.68NA
Q3 2022
11/8/2022
1.23-0.35-1.40NA
Q2 2022
8/4/2022
1.63-0.37-1.48NA
Q1 2022
5/5/2022
1.61-0.37-1.48NA
Q4 2021
3/1/2022
3.54-0.40-1.60NA
Q3 2021
11/4/2021
5.98-0.35-1.40NA
Q2 2021
8/5/2021
5.79-0.30-1.20NA
Q1 2021
5/6/2021
8.15-0.26-1.04NA
Q4 2020
2/24/2021
8.04-0.31-1.24NA
Q3 2020
11/5/2020
7.07-0.32-1.28NA
Q2 2020
8/6/2020
7.55-0.34-1.36NA
Q1 2020
5/7/2020
12.250.261.0411.8
Q4 2019
2/27/2020
7.12-0.79-3.16NA
Q3 2019
11/7/2019
6.15-0.52-2.08NA
Q2 2019
8/7/2019
10.92-0.64-2.56NA
Q1 2019
5/9/2019
10.04-0.31-1.24NA
Q4 2018
2/27/2019
12.73-0.74-2.96NA
Q3 2018
11/6/2018
12.75-0.53-2.12NA
Q2 2018
8/8/2018
25.40-0.35-1.40NA
Q1 2018
5/9/2018
24.40-0.40-1.60NA
Q4 2017
3/7/2018
33.870.030.12282.2
Q3 2017
11/7/2017
19.70-0.28-1.12NA
Q2 2017
8/7/2017
13.65-0.69-2.76NA
Q1 2017
5/5/2017
14.97-0.23-0.92NA
Q4 2016
3/2/2017
14.50-0.39-1.56NA
Q3 2016
11/3/2016
10.95-0.40-1.60NA
Q2 2016
8/3/2016
10.46-0.39-1.56NA
Q1 2016
5/6/2016
12.11-0.44-1.76NA
Q4 2015
3/7/2016
13.22-0.39-1.56NA
Q3 2015
11/23/2015
16.00-14.26-57.04NA
CytomX Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/11/2024
2.510.01-0.02NA
Q3 2023
11/7/2023
1.280.04-0.45NA
Q2 2023
8/8/2023
1.69-0.02-0.84NA
Q1 2023
5/9/2023
1.72-0.05-1.19NA
Q4 2022
3/27/2023
1.79-0.42-1.51NA
Q3 2022
11/8/2022
1.23-0.35-1.49NA
Q2 2022
8/4/2022
1.63-0.37-1.49NA
Q1 2022
5/5/2022
1.61-0.37-1.42NA
Q4 2021
3/1/2022
3.54-0.40-1.31NA
Q3 2021
11/4/2021
5.98-0.35-1.22NA
Q2 2021
8/5/2021
5.79-0.30-1.19NA
Q1 2021
5/6/2021
8.15-0.26-1.23NA
Q4 2020
2/24/2021
8.04-0.31-0.71NA
Q3 2020
11/5/2020
7.07-0.32-1.19NA
Q2 2020
8/6/2020
7.55-0.34-1.39NA
Q1 2020
5/7/2020
12.250.26-1.69NA
Q4 2019
2/27/2020
7.12-0.79-2.26NA
Q3 2019
11/7/2019
6.15-0.52-2.21NA
Q2 2019
8/7/2019
10.92-0.64-2.22NA
Q1 2019
5/9/2019
10.04-0.31-1.93NA
Q4 2018
2/27/2019
12.73-0.74-2.02NA
Q3 2018
11/6/2018
12.75-0.53-1.25NA
Q2 2018
8/8/2018
25.40-0.35-1.00NA
Q1 2018
5/9/2018
24.40-0.40-1.34NA
Q4 2017
3/7/2018
33.870.03-1.17NA
Q3 2017
11/7/2017
19.70-0.28-1.59NA
Q2 2017
8/7/2017
13.65-0.69-1.71NA
Q1 2017
5/5/2017
14.97-0.23-1.41NA
Q4 2016
3/2/2017
14.50-0.39-1.62NA
Q3 2016
11/3/2016
10.95-0.40-1.62NA
Q2 2016
8/3/2016
10.46-0.39-15.48NA
Q1 2016
5/6/2016
12.11-0.44NANA
Q4 2015
3/7/2016
13.22-0.39NANA
Q3 2015
11/23/2015
16.00-14.26NANA
Quotes delayed 20 minutes

Email EnvelopeFree CTMX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
CytomX Therapeutics (CTMX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CTSO PE Ratio History
CTXR PE Ratio History
CUE PE Ratio History
CUTR PE Ratio History
CVRX PE Ratio History
CVS PE Ratio History
CWBR PE Ratio History
CYCC PE Ratio History
CYCN PE Ratio History
CYH PE Ratio History
How should the CTMX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like CytomX Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CTMX Historical PE Ratio page.

What is the average historical PE for CTMX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CTMX historical PE ratio using the annualized quarterly earnings method works out to 91.2.

What is the average historical PE for CTMX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CTMX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the CytomX Therapeutics Historical PE Ratio information for CytomX Therapeutics' stock. The average CTMX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 91.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CTMX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CTMX historical PE result, against the recent PE: when this page was posted on 3/22/2024, the most recent closing price for CTMX had been 2.11, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent CTMX PE on 3/22/2024 based on annualized quarterly EPS was 52.7. Based on CTMX's history, that recent PE is low relative to the historical average, with the recent PE 42.2% lower than the historical average PE across our data set for CytomX Therapeutics.

For self directed investors doing their due diligence on CTMX or any other given stock, valuation analysis for CTMX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate CytomX Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CTMX. Thanks for visiting, and the next time you need to research CTMX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: NCLH MACD, ORN Average Annual Return, EUMF market cap history.

 

CytomX Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.